NETRI, a TechBio company combining human neuron-based technology and AI-powered analytics to improve drug development, has been named the winner of the 2026 Amgen x NSG BioLabs Golden Ticket in Singapore. The award is part of a joint programme by Amgen, a leader in biologic medicines, and NSG BioLabs, Singapore’s leading provider of biotechnology co-working laboratories and offices.
